ALS Treatment Candidate NPT520-34 Being Tested in Phase 1 Trial – ALS News Today

ALS Treatment Candidate NPT520-34 Being Tested in Phase 1 Trial – ALS News Today
ALS Treatment Candidate NPT520-34 Being Tested in Phase 1 Trial  ALS News TodayNeuropore has launched a Phase 1 trial testing NPT520-34 to assess its safety, tolerability, and pharmacokinetic properties in healthy volunteers. ... read more
Source: Google NewsPublished on 2019-05-13